IntroductionThough liver owns a considerable inherent regenerate ability, continuous and chronic injury leads to the onset of hepatic cirrhosis. Various stimuli such as hepatitis virus, alcohol, drugs, and autoimmune assault by hepatic cells can touch off hepatocyte apoptosis, damage the endothelial barrier, accumulate the inflammatory cells, and activate hepatic stellate cells. In China, chronic hepatitis B virus (HBV) infection is the major factor of liver cirrhosis (LC). LC generally progresses irreversibly into a decompensated phase, which is featured by a sequence of clinical manifestations, including ascites, variceal hemorrhage, and hepatic encephalopathy. Apparently, hepatic cirrhosis is easy to progress to liver failure, and the condition of patient in hepatic failure with accompanying LC is more serious, and the prognosis is worse. Currently, the most effective therapy for end‐stage LC is liver transplantation. However, transplantation is limited by a shortage of donor organs, surgical complications, immunological rejection, and high medical expense.While originally isolated from bone marrow, mesenchymal stem cells (MSCs) are widely distributed in the postnatal organism and adult organs or tissues, which are multipotent stromal cells with self‐renewing potential characterized by their capacity to differentiate into the cells of the mesodermal and ectodermal lineage. Furthermore, a large quantity of experiments
Journal of Gastroenterology and Hepatology – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera